|
Nasdaq:AVGN
Avigen,
Inc. is focused on the development of gene therapy products for the treatment
of disease. The Company has developed a proprietary technology based on
adeno-associated virus (AAV) vectors. This technology is designed to deliver
DNA into cells of patients in order to produce therapeutic results as an
alternative to existing pharmaceutical and surgical treatments
1301 Harbor Bay Parkway Alameda,
CA 94502
Phone: (510) 748-7150
|